[go: up one dir, main page]

AR062874A1 - Composiciones farmaceuticas que contienen rosuvastatina calcio - Google Patents

Composiciones farmaceuticas que contienen rosuvastatina calcio

Info

Publication number
AR062874A1
AR062874A1 ARP070104111A ARP070104111A AR062874A1 AR 062874 A1 AR062874 A1 AR 062874A1 AR P070104111 A ARP070104111 A AR P070104111A AR P070104111 A ARP070104111 A AR P070104111A AR 062874 A1 AR062874 A1 AR 062874A1
Authority
AR
Argentina
Prior art keywords
calcium
rosuvastatina
pharmaceutical compositions
compositions containing
pharmaceutical composition
Prior art date
Application number
ARP070104111A
Other languages
English (en)
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of AR062874A1 publication Critical patent/AR062874A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composicion farmacéutica nueva que contiene rosuvastatina calcio amorfo, e hidroxido de magnesio y/o acetato de calcio, o gluconato de calcio, o glicerofosfato de calcio, o hidroxido de aluminio, como aditivo estabilizador y uno o más excipientes aceptables desde el punto de vista farmacéutico. Proceso.
ARP070104111A 2006-09-18 2007-09-17 Composiciones farmaceuticas que contienen rosuvastatina calcio AR062874A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0600728A HU227610B1 (en) 2006-09-18 2006-09-18 Pharmaceutical compositions containing rosuvastatin potassium

Publications (1)

Publication Number Publication Date
AR062874A1 true AR062874A1 (es) 2008-12-10

Family

ID=89987035

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070104111A AR062874A1 (es) 2006-09-18 2007-09-17 Composiciones farmaceuticas que contienen rosuvastatina calcio

Country Status (24)

Country Link
US (1) US8221788B2 (es)
EP (1) EP2063868B1 (es)
JP (1) JP5534812B2 (es)
CN (1) CN101516349A (es)
AR (1) AR062874A1 (es)
AT (1) ATE489078T1 (es)
AU (1) AU2007298751B2 (es)
CA (1) CA2662919C (es)
CY (1) CY1114533T1 (es)
DE (1) DE602007010797D1 (es)
DK (1) DK2063868T3 (es)
EA (1) EA014451B1 (es)
ES (1) ES2357263T3 (es)
HR (1) HRP20110125T1 (es)
HU (1) HU227610B1 (es)
JO (1) JO2641B1 (es)
ME (1) ME01944B (es)
PL (1) PL2063868T3 (es)
PT (1) PT2063868E (es)
RS (1) RS51563B (es)
SI (1) SI2063868T1 (es)
TW (1) TWI454265B (es)
UA (1) UA97489C2 (es)
WO (1) WO2008035128A1 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666445B2 (en) * 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
TR200800269A2 (tr) * 2008-01-15 2009-08-21 Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş. Stabil farmasötik formülasyon ve hazırlama yöntemleri
EP2815751A1 (en) 2008-01-28 2014-12-24 Beauty Pearl Group Limited Compositions comprising calcium, magnesium, zinc, and vitamin D3 for the prevention and amelioration of osteoporosis
WO2009112870A1 (en) * 2008-03-11 2009-09-17 Belupo-Lijekovi I Kozmetika D.D. Pharmaceutical composition comprising rosuvastatin calcium and magnesium carbonate hydroxide pentahydrate as a stabilizer
PL2309992T3 (pl) * 2008-06-27 2018-05-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Kompozycja farmaceutyczna zawierająca statynę
EP2138165A1 (en) 2008-06-27 2009-12-30 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical composition comprising a statin
PL386051A1 (pl) * 2008-09-09 2010-03-15 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Stabilna doustna kompozycja farmaceutyczna zawierająca farmaceutycznie dopuszczalną sól kwsu [(E)-7-[4-(4-fluorofenylo)-6-izopropylo-2-[metylo(metylosulfonylo)amino]pirymidyn-5-ylo] (3R,5S)-3,5-dihydroksyhept-6-enowego
TR200904341A2 (tr) 2009-06-03 2010-12-21 Bi̇lgi̇ç Mahmut Rosuvastatin kalsiyum içeren kararlı farmasötik bileşimler.
WO2011139256A2 (en) 2010-05-04 2011-11-10 Bilgic Mahmut Stable rosuvastatin formulations
CN101972260B (zh) * 2010-11-24 2012-05-02 天津市汉康医药生物技术有限公司 一种瑞舒伐他汀钙口服药物组合物
KR20200003219A (ko) * 2011-05-20 2020-01-08 아스트라제네카 유케이 리미티드 로수바스타틴 칼슘의 약학 조성물
CN102860994B (zh) * 2011-07-04 2016-01-20 石药集团中奇制药技术（石家庄）有限公司 一种瑞舒伐他汀钙片及其制备方法
CN116768882A (zh) 2012-09-18 2023-09-19 奥斯拜客斯制药有限公司 化合物、及其药物组合物及治疗方法
US9550780B2 (en) 2012-09-18 2017-01-24 Auspex Pharmaceuticals, Inc. Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
CN102908335B (zh) * 2012-11-19 2015-04-08 山东罗欣药业集团股份有限公司 一种瑞舒伐他汀钙组合物及其制备方法
CN103961354A (zh) * 2013-02-05 2014-08-06 深圳信立泰药业股份有限公司 一种稳定的瑞舒伐他汀钙药物组合物及其制备方法
RO129060B1 (ro) 2013-04-25 2014-11-28 Antibiotice S.A. Compoziţie farmaceutică stabilă cu rosuvastatină calcică amorfă
RU2547574C2 (ru) * 2013-07-09 2015-04-10 Общество с ограниченной ответственностью "Трейдсервис" Лекарственная форма гиполипидемического действия и способ ее изготовления
CN103494788B (zh) * 2013-10-10 2015-08-05 齐晓彤 瑞舒伐他汀钙片的药物组合物及其制备方法
MX369956B (es) 2013-12-03 2019-11-27 Auspex Pharmaceuticals Inc Metodos para preparar compuestos de benzoquinolina.
CN107072997A (zh) * 2014-11-11 2017-08-18 盐野义制药株式会社 含有对光不稳定的药物的多层片剂
CN104523650B (zh) * 2014-12-20 2017-04-12 山东新时代药业有限公司 一种含有瑞舒伐他汀钙的胶囊
US20160287574A1 (en) 2015-03-06 2016-10-06 Auspex Pharmaceuticals, Inc. Methods for the treatment of abnormal involuntary movement disorders
JP2016169198A (ja) * 2015-03-13 2016-09-23 大原薬品工業株式会社 ロスバスタチンカルシウムを含有する錠剤
JP6095176B2 (ja) * 2015-04-24 2017-03-15 大原薬品工業株式会社 ロスバスタチンカルシウムの光安定性が向上したフィルムコーティング錠剤
CN104840964B (zh) * 2015-05-07 2018-01-16 南京正大天晴制药有限公司 一种稳定的索氟布韦药物组合物及其制备方法
CN105168158B (zh) * 2015-08-18 2018-08-03 上海韬鸿化工科技有限公司 一种瑞舒伐他汀钙分散片及其制备方法
EP3243506A1 (en) 2016-05-09 2017-11-15 Adamed sp. z o.o. Pharmaceutical composition
CN108245516B (zh) * 2017-11-09 2019-04-12 浙江京新药业股份有限公司 一种含瑞舒伐他汀钙的药物组合物及其制备方法
CN112274487A (zh) * 2019-07-25 2021-01-29 北京福元医药股份有限公司 一种瑞舒伐他汀钙药物制剂
CN115317455B (zh) * 2022-08-17 2023-08-22 新发药业有限公司 一种药片含量均匀、易于溶出的瑞舒伐他汀钙片及其制备方法
GB2622822A (en) 2022-09-28 2024-04-03 Novumgen Ltd A rapidly disintegrating tablet of rosuvastatin and its process of preparation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180589A (en) * 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
SI20109A (sl) * 1998-12-16 2000-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Stabilna farmacevtska formulacija
US6569461B1 (en) * 1999-03-08 2003-05-27 Merck & Co., Inc. Dihydroxy open-acid and salts of HMG-CoA reductase inhibitors
MXPA02000676A (es) * 1999-07-20 2002-08-30 3M Innovative Properties Co Uso de cetonas fluoradas en composiciones para extincion de incendios.
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
US20030031720A1 (en) * 2000-02-24 2003-02-13 Tobias Laich Method for producing pharmaceutical dosage forms
GB0111077D0 (en) * 2001-05-04 2001-06-27 Biochemie Gmbh Organic compounds
OA12777A (en) * 2002-02-14 2006-07-06 Ranbaxy Lab Ltd Formulations of atorvastatin stabilized with alkali metal additions.
GB0217306D0 (en) * 2002-07-25 2002-09-04 Novartis Ag Compositions comprising organic compounds
SI21400A (sl) * 2003-02-12 2004-08-31 LEK farmacevtska družba d.d. Stabilna farmacevtska oblika z inhibitorjem HMG-CoA reduktaze
AU2003269478A1 (en) * 2003-08-27 2005-03-16 Hetero Drugs Limited A novel process for amorphous rosuvastatin calcium
CA2597492A1 (en) * 2005-02-10 2006-08-17 Lifecycle Pharma A/S A stable pharmaceutical composition comprising a fixed dose combination of fenofibrate and an hmg-coa reductase inhibitor
US20070202159A1 (en) * 2006-02-02 2007-08-30 Mathur Rajeev S Pharmaceutical composition comprising stabilized statin particles

Also Published As

Publication number Publication date
ATE489078T1 (de) 2010-12-15
CA2662919C (en) 2013-04-30
TW200829246A (en) 2008-07-16
PT2063868E (pt) 2010-12-23
ME01944B (me) 2011-08-31
PL2063868T3 (pl) 2011-05-31
EP2063868A1 (en) 2009-06-03
HUP0600728A2 (en) 2008-06-30
EA014451B1 (ru) 2010-12-30
TWI454265B (zh) 2014-10-01
CY1114533T1 (el) 2016-10-05
WO2008035128A1 (en) 2008-03-27
US8221788B2 (en) 2012-07-17
ES2357263T3 (es) 2011-04-20
DK2063868T3 (da) 2011-02-07
SI2063868T1 (sl) 2011-03-31
EP2063868B1 (en) 2010-11-24
DE602007010797D1 (de) 2011-01-05
HU0600728D0 (en) 2006-11-28
CA2662919A1 (en) 2008-03-27
HU227610B1 (en) 2011-09-28
HRP20110125T1 (hr) 2011-03-31
CN101516349A (zh) 2009-08-26
UA97489C2 (ru) 2012-02-27
EA200970291A1 (ru) 2009-06-30
US20090297599A1 (en) 2009-12-03
AU2007298751A1 (en) 2008-03-27
RS51563B (sr) 2011-08-31
JP5534812B2 (ja) 2014-07-02
AU2007298751B2 (en) 2013-05-02
JO2641B1 (en) 2012-06-17
JP2010503723A (ja) 2010-02-04

Similar Documents

Publication Publication Date Title
AR062874A1 (es) Composiciones farmaceuticas que contienen rosuvastatina calcio
GT200800276A (es) Composiciones farmaceuticas estabilizadas que comprenden fesoterodina
CR10748A (es) Compuesto de indol
EP2104674B8 (en) Thiophene analogues for the treatment or prevention of flavivirus infections
CL2007002234A1 (es) Compuestos derivados de heterociclos de nitrogeno; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de enfermedades proliferativas.
AR089931A1 (es) Composiciones farmaceuticas que contienen dimetilfumarato
EA201690107A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
MX2010007083A (es) Combinacion anti-retroviral.
IL193252A0 (en) N-hydroxyacrylamide compounds
EA201790726A1 (ru) Фармацевтическая композиция для лечения язвенного колита
BR122020011180B8 (pt) formulações injetáveis de compostos de tetraciclina
PH12018500378A1 (en) Novel annelated phenoxyacetamides
CL2008001990A1 (es) Compuestos derivados de amino-quinazolinas sustituidas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de alzheimer.
TN2012000105A1 (en) Spirolactam derivatives and uses of same
EA201170101A1 (ru) Фармацевтические композиции роувастатина кальция
CL2007000485A1 (es) Sal de alisquereno; procedimiento de preparacion; composicion farmaceutica que comprende a dicha sal; y uso del compuesto para el tratamiento de enfermedades que puedan ser moduladas mediante la inhibicion de la renina.
TW200800993A (en) Organic compounds
EP2611799A4 (en) PHARMACEUTICAL COMPOSITIONS OF LINEZOLID
PA8815101A1 (es) Asoc. entre unasal de bis-tiazolio o uno de sus precursosres y artemisinina o uno de sus derivados para el trat.......
BR112015010119A2 (pt) composição farmacêutica que contém um inibidor de ace e um bloqueador do canal de cálcio
EA200870236A1 (ru) Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе
BR112012006433A2 (pt) composição de libertação sustentada de ranolazina
AR062613A1 (es) Formulacion de compuestos organicos
CR20110342A (es) Compuestos ciclopropilo
DE602006008339D1 (en) Zolpidemtabletten

Legal Events

Date Code Title Description
FB Suspension of granting procedure